{
    "address": "Viikinkaari 4",
    "city": "Helsinki",
    "country": "FI",
    "currency": "EUR",
    "cusip": "X5602Q107",
    "description": "Nanoform Finland Oy engages in providing expert services in nanotechnology and drug particle engineering for the international pharma industry. The company is headquartered in Helsinki, Etela-Suomen and currently employs 87 full-time employees. The company went IPO on 2020-06-04. The Company\u2019s affairs consist of both internal research and development activities and proof of concept type of research and development services provided to customers.",
    "employeeTotal": "87.0",
    "exchange": "NASDAQ OMX HELSINKI LTD.",
    "finnhubIndustry": "Life Sciences Tools & Services",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Life Sciences Tools & Services",
    "gsector": "Health Care",
    "gsubind": "Life Sciences Tools & Services",
    "ipo": "2020-06-04",
    "isin": "FI4000330972",
    "logo": "",
    "marketCapitalization": 514.9995,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Nanoform Finland Plc",
    "phone": "358293700150.0",
    "sedol": "BMBM5J2",
    "shareOutstanding": 72.535146,
    "state": "ETELA-SUOMEN",
    "ticker": "NANOFH.HE",
    "weburl": "https://nanoform.com/"
}